SCINAI IMMUNOTHERAPEUTICS LTD. Accumulated Other Comprehensive Income
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Accumulated Other Comprehensive Income of -$1.74 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-04-01
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.74M.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.74M.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.74M.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.74M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | -$1.74M 20-F · filed 2026-04-01 |
| 2025-06-30 | -$1.74M 6-K · filed 2025-09-02 |
| 2024-12-31 | -$1.74M 20-F · filed 2026-04-01 |
| 2024-06-30 | -$1.74M 6-K · filed 2024-09-09 |
| 2023-12-31 | -$1.74M 20-F · filed 2025-05-07 |
| 2023-06-30 | -$1.74M 6-K/A · filed 2023-08-18 |
| 2023-03-31 | -$1.89M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$2.01M 20-F · filed 2024-05-15 |
| 2021-12-31 | -$2.06M 10-K · filed 2023-04-17 |